Genetic Test Helps Differentiate Benign vs Malignant Thyroid Nodules
A multigene genomic classifier (GC) test for thyroid nodules with indeterminate cytology shows high sensitivity and negative predictive value.
Thyroid Cancer
THYROID CANCER
Featured Article
Latest News
Preventing Unnecessary Thyroid Biopsies: A Comparison of 5 Sonographic Risk Stratification Systems
The best overall performance was that of the ACR Thyroid Imaging Reporting and Data System, which classified more than half of the requested biopsies as unnecessary.
Obesity Not Associated With Worse Outcomes in Thyroid Cancer
Obesity was not associated with more aggressive clinicopathologic features of thyroid cancer.
Rates of Lobectomy vs Thyroidectomy for Low-Risk Differentiated Thyroid Cancer
Adherence to the 2015 recommendation from ATA — to use lobectomy rather than complete thyroidectomy for low-risk differentiated thyroid cancer — is increasing.
Childhood Radiation-Induced Thyroid Cancer Does Not Lower All-Cause Survival
Childhood radiation-induced thyroid cancer does not affect all-cause mortality compared with healthy individuals.
Malignancy Rates Higher in Children With Indeterminate Thyroid Nodules
Malignancy was more common in children with thyroid nodules classified as indeterminate by BSRTC criteria compared with adults.
BABA Robotic Thyroidectomy Determined to Be Safe and Effective
The BABA robotic thyroidectomy technique appears to be safe, with excellent outcomes in benign and malignant thyroid disease.
Ethanol Sensitization May Improve RFA of Benign Thyroid Nodules
Ethanol sensitization before radiofrequency ablation of benign thyroid nodules reduced time, ablation energy, and complications compared with conventional ablation.
Recombinant Human Thyrotropin vs Thyroid Hormone Withdrawal After Radioiodine Therapy in Thyroid Cancer
Outcomes after radioiodine therapy are similar after preparation with either recombinant human thyrotropin or thyroid hormone withdrawal.
US Centers Fail to Analyze Neck Lymph Nodes in Preoperative Ultrasounds for Thyroid Cancer
Most imaging centers in the United States fail to analyze lateral neck lymph nodes during preoperative ultrasounds in patients with thyroid cancer.
Male Thyroid Cancer Survivors Face Higher CVD Risk
Male thyroid cancer survivors have a nearly 50 percent higher risk of developing CVD than female survivors within five years of cancer diagnosis.
RET Inhibitor Gets Breakthrough Treatment Status for Medullary Thyroid Cancer
LOXO-292 is being evaluated in the ongoing Phase 1/2 LIBRETTO-001 clinical trial.
Want to read more?
Please login or register first to view this content.
